Horizon Pharma, Inc.

NASDAQ: HZNP
$85.13
+$2.22 (+2.7%)
Closing price June 24, 2022
Wednesday's top analyst upgrades and downgrades included Accenture, Bridgebio Pharma, Chesapeake Energy, eBay, Hewlett Packard Enterprise, Huntsman, New York Community Bancorp, Nucor, Oracle, PBF...
Tuesday's top analyst upgrades and downgrades included Best Buy, Cigna, Exxon Mobil, Futu, GoodRx, Lululemon Athletica, Merck, Monster Beverage, MP Materials, Nike, Visa and Walmart.
Friday's top analyst upgrades and downgrades included AbbVie, Amazon.com, APA, CF Industries, Costco Wholesale, eBay, Etsy, GoDaddy, Intercontinental Exchange, Lululemon Athletica, Match, MetLife,...
Tuesday's top analyst upgrades and downgrades included Amgen, Array Technologies, Boeing, Carvana, DocuSign, Enterprise Products Partners, Fiserv, Johnson Controls, Monster Beverage, Nvidia, PayPal,...
Wednesday's top analyst upgrades and downgrades included APA, Archer Daniels Midland, Coupa Software, Diamondback Energy, eBay, Micron Technology, Nvidia, Pioneer Natural Resources, Ross Stores, SoFi...
Wednesday afternoon's top analyst upgrades and downgrades included AeroVironment, AutoZone, BigCommerce, NXP Semiconductors, Roblox, Stitch Fix and more.
Thursday afternoon's analyst upgrades and downgrades included Amazon, Bank of America, BioNTech, Chipotle, Disney and more.
The drastic changes in the way business is being done now may be here for good. These four Jefferies growth stock picks look poised to advance into the future and have some big upside to the firm's...
Friday's top analyst upgrades and downgrades included AerCap, Barclays, Denny's, DocuSign, Intercontinental Hotels, Lennar, Luminar Technologies and Quest Diagnostics.
The MSCI indexes are rebalanced twice a year, and at the end of November, a huge rebalance is set to occur. That means some major buying in some very well-known companies.
These five high-conviction health care stock picks from the analysts at Jefferies all make sense for investors looking to gain exposure to a sector that should continue to do well the rest of 2020...
These four high-conviction health care stock ideas from the analysts at Jefferies all make sense for investors looking to gain exposure to a sector that should continue to do well the rest of 2020...
Horizon Pharma shares exploded on Thursday after the firm announced results from its late-stage trial evaluating teprotumumab for the treatment of active thyroid eye disease.
The top analyst upgrades, downgrades and other research calls from Wednesday included Altice, Blue Apron, CubeSmart, Horizon Pharma, KB Home, Las Vegas Sands, Mylan and Switch.
The top analyst upgrades, downgrades and other research calls from Monday include Applied Materials, Barrick Gold, Comcast, GoDaddy, Intel, PG&E, Qualcomm and Sirius XM.